IVIVC and Waivers: How In-Vitro Testing Is Replacing In-Vivo Bioequivalence Studies
IVIVC lets pharmaceutical companies replace costly human bioequivalence trials with lab-based dissolution tests. When done correctly, it saves millions and speeds up generic drug approvals - but only a fraction of submissions succeed.
Continue reading...
